Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS
· Delayed Price · Currency is USD
0.0052
0.00 (0.00%)
At close: Apr 28, 2026
Ampio Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
5.90K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Theralink Technologies | 635.45K |
| Syros Pharmaceuticals | 386.00K |
| MultiCell Technologies | 805.24K |
| Therapeutic Solutions International | 85.32K |
| Bioasis Technologies | 199.01K |
| Kaleido Biosciences | 1.10M |
Ampio Pharmaceuticals News
- 2 years ago - Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation - PRNewsWire
- 2 years ago - Ampio Announces Voluntary Delisting and SEC Deregistration - PRNewsWire
- 2 years ago - Ampio Provides Update on Results from Pre-IND Enabling Studies - PRNewsWire
- 2 years ago - Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions - PRNewsWire
- 2 years ago - Ampio Pharmaceuticals to Present at the Emerging Growth Conference - PRNewsWire
- 2 years ago - Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 - PRNewsWire
- 2 years ago - Ampio Pharmaceuticals Announces Reverse Stock Split - PRNewsWire
- 3 years ago - Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock - PRNewsWire